# Watson-Marlow approves £24M investment for BioPure facility in Portsmouth

Watson-Marlow Fluid Technology Group approved a £24 million investment to construct an 11,000 sqm manufacturing facility in Portsmouth, UK for BioPure, which supplies fluid path technologies for the pharmaceutical and biotechnology sector.

- Type: Investment
- Announced: 2021-06-01
- Where: Portsmouth, UK, United Kingdom
- Value: $34.0M (24.0M GBP)
- Status: announced
- Capacity: 11000 sqm
- Products: fluid path technologies
- Sectors: [Pumps and Valves](https://endata.com/sectors/pumps-valves.md)

## Companies

- [Watson-Marlow Fluid Technology Group](https://endata.com/companies/487.md)
- [BioPure](https://endata.com/companies/55511.md)

## Sources

- [manufacturingchemist.com](https://manufacturingchemist.com/watson-marlow-invests-in-manufacturing-capacity-176945), 2021-06-01: "We’ve always been a business that believes in investment and innovation – and our plans to expand our capacity in three of our business brands is proof of our commitment."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.